(2S)-4-{[(benzyloxy)carbonyl]amino}-2-{[(tert-butoxy)carbonyl]amino}butanoic acid
Boc-Dab(Z)-OH . DCHA
CAS: 16947-89-0
Molecular Formula: C17H24N2O6
(2S)-4-{[(benzyloxy)carbonyl]amino}-2-{[(tert-butoxy)carbonyl]amino}butanoic acid - Names and Identifiers
| Name | Boc-Dab(Z)-OH . DCHA |
| Synonyms | BOC-DAB(Z)-OH DCHA Boc-Dab(Z)-OH·DCHA Boc-Dab(Z)-OH . DCHA BOC-L-DAB(Z)-OH DCHA N-cyclohexylcyclohexanamine Alpha-Boc-Gamma-Z-(Dl)-Diaminobutyric Acid ALPHA-BOC-GAMMA-Z-(DL)-DIAMINOBUTYRIC ACID BOC-ALPHA,GAMMA-DIAMINOBUTYRIC ACID(Z)-OH DCHA (2S)-2-(tert-butoxycarbonylamino)-4-(carboxyamino)butanoic acid BOC-N-GAMMA-Z-L-2,4-DIAMINOBUTYRIC ACID DICYCLOHEXYLAMMONIUM SALT N-alpha-Boc-Ngamma-Z-L-2,4-diaminobutyric acid dicyclohexylammonium salt (2S)-4-{[(benzyloxy)carbonyl]amino}-2-{[(tert-butoxy)carbonyl]amino}butanoic acid (S)-2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-4-[[(PHENYLMETHOXY)CARBONYL]AMINO] BUTANOIC ACID, DICYCLOHEXYLAMINE SALT |
| CAS | 16947-89-0 |
| InChI | InChI=1/C12H23N.C10H18N2O6.C8H10/c1-3-7-11(8-4-1)13-12-9-5-2-6-10-12;1-10(2,3)18-9(17)12-6(7(13)14)4-5-11-8(15)16;1-2-8-6-4-3-5-7-8/h11-13H,1-10H2;6,11H,4-5H2,1-3H3,(H,12,17)(H,13,14)(H,15,16);3-7H,2H2,1H3/t;6-;/m.0./s1 |
(2S)-4-{[(benzyloxy)carbonyl]amino}-2-{[(tert-butoxy)carbonyl]amino}butanoic acid - Physico-chemical Properties
| Molecular Formula | C17H24N2O6 |
| Molar Mass | 352.38 |
| Boling Point | 719.6°C at 760 mmHg |
| Flash Point | 389°C |
| Vapor Presure | 9.85E-22mmHg at 25°C |
| Storage Condition | Inert atmosphere,2-8°C |
(2S)-4-{[(benzyloxy)carbonyl]amino}-2-{[(tert-butoxy)carbonyl]amino}butanoic acid - Introduction
Boc-Dab(Z)-OH . DCHA is a drug molecule, usually abbreviated as CBDA, with the chemical structure N-(tert-butoxycarbonyl)-N'-benzyloxycarbonyl-L-2,4-diaminobutanoic acid dihexylamine salt.
CBDA is a white solid with good stability at room temperature. It is soluble in commonly used solvents such as ethanol and dimethyl sulfoxide.
CBDA has many uses. As an intermediate in the field of pharmaceutical research, it is commonly used in the synthesis of polypeptide drugs and analogs of natural products. In addition, CBDA can also be used as a protein cross-linking reagent and ribonucleic acid (DNA/RNA) cross-linking reagent.
The preparation method of CBDA generally includes the following steps: First, L-2, 4-diaminobutyric acid is reacted with tert-butyryl chloride to obtain N-tert-butoxycarbonyl-L-2,4-diaminobutyric acid; Then, the obtained product is reacted with benzyl alcohol to generate N-tert-butoxycarbonyl-N'-benzyloxycarbonyl-L-2, 4-diaminobutyric acid; Finally, this molecule is reacted with cyclohexylamine to form the dicyclohexylamine salt.
The safety information of CBDA is not particularly clear. Because it is a pharmaceutical intermediate, appropriate chemical laboratory safety measures should be taken during handling and handling, such as wearing personal protective equipment, maintaining good ventilation, and avoiding inhalation or contact with skin and eyes. If you have accidentally ingested or come into contact with CBDA, you should seek medical help immediately and bring along the product label or container for reference.
CBDA is a white solid with good stability at room temperature. It is soluble in commonly used solvents such as ethanol and dimethyl sulfoxide.
CBDA has many uses. As an intermediate in the field of pharmaceutical research, it is commonly used in the synthesis of polypeptide drugs and analogs of natural products. In addition, CBDA can also be used as a protein cross-linking reagent and ribonucleic acid (DNA/RNA) cross-linking reagent.
The preparation method of CBDA generally includes the following steps: First, L-2, 4-diaminobutyric acid is reacted with tert-butyryl chloride to obtain N-tert-butoxycarbonyl-L-2,4-diaminobutyric acid; Then, the obtained product is reacted with benzyl alcohol to generate N-tert-butoxycarbonyl-N'-benzyloxycarbonyl-L-2, 4-diaminobutyric acid; Finally, this molecule is reacted with cyclohexylamine to form the dicyclohexylamine salt.
The safety information of CBDA is not particularly clear. Because it is a pharmaceutical intermediate, appropriate chemical laboratory safety measures should be taken during handling and handling, such as wearing personal protective equipment, maintaining good ventilation, and avoiding inhalation or contact with skin and eyes. If you have accidentally ingested or come into contact with CBDA, you should seek medical help immediately and bring along the product label or container for reference.
Last Update：2024-04-09 21:01:54
![(2S)-4-{[(benzyloxy)carbonyl]amino}-2-{[(tert-butoxy)carbonyl]amino}butanoic acid](http://res.chembk.com/assets/images/structure/16947-89-0.gif)
Supplier List
Product Name: ALPHA-BOC-GAMMA-Z-(DL)-DIAMINOBUTYRIC ACID Visit Supplier Webpage Request for quotation
CAS: 16947-89-0
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 16947-89-0
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Product Name: ALPHA-BOC-GAMMA-Z-(DL)-DIAMINOBUTYRIC ACID Visit Supplier Webpage Request for quotation
CAS: 16947-89-0
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 16947-89-0
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History